臨床外科72巻3号

2017年03月発行

FOCUS

消化器疾患・高度侵襲時におけるシンバイオティクス療法の有用性

著者： 本告正明¹

所属機関： ¹大阪府立急性期・総合医療センター消化器外科

ページ範囲：P.323 - P.328

文献概要

はじめに
　近年，腸内細菌叢の研究が進み，腸内環境の乱れはさまざまな疾患の原因になることが明らかになってきた．また，腸管は高度侵襲時の標的臓器であり，侵襲により腸内環境は大きく乱れる．有用菌であるプロバイオティクスとその増殖因子であるプレバイオティクスを併用するシンバイオティクス療法は，腸内環境を整える方法として注目されている．本稿では，腸内環境の乱れが原因とされている消化器疾患や，高度侵襲時の重症感染症予防におけるシンバイオティクスの有用性について概説する．

参考文献

1）Vollaard EJ, Clasener HA：Colonization resistance. Antimicrob Agents Chemother 38：409-414, 1994

2）Furusawa Y, Obata Y, Fukuda S, et al：Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature 504：446-450, 2013

3）Yin L, Laevsky G, Giardina C：Butyrate suppression of colonocyte NF-kappa B activation and cellular proteasome activity. J Biol Chem 276：44641-44646, 2001

4）Takahashi T, Nakagawa E, Nara T, et al：Effects of orally ingested Bifidobacterium longum on the mucosal IgA response of mice to dietary antigens. Biosci Biotechnol Biochem 62：10-15, 1998

5）Miele L, Valenza V, La Torre G, et al：Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease. Hepatology 49：1877-1887, 2009

6）Harte AL1, da Silva NF, Creely SJ, et al：Elevated endotoxin levels in non-alcoholic fatty liver disease. J Inflamm（Lond）7：15, 2010

7）Aller R, De Luis DA, Izaola O, et al：Effect of a probiotic on liver aminotransferases in nonalcoholic fatty liver disease patients：a double blind randomized clinical trial. Eur Rev Med Pharmacol Sci 15：1090-1095, 2011

8）Eslamparast T, Poustchi H, Zamani F, et al：Synbiotic supplementation in nonalcoholic fatty liver disease：a randomized, double-blind, placebo-controlled pilot study. Am J Clin Nutr 99：535-542, 2014

9）Loh G, Blaut M：Role of commensal gut bacteria in inflammatory bowel diseases. Gut Microbes 3：544-555, 2012

10）Atarashi K, Tanoue T, Shima T, et al：Induction of colonic regulatory T cells by indigenous Clostridium species. Science 331：337-341, 2011

11）Peloquin JM, Nguyen DD：The microbiota and inflammatory bowel disease：insights from animal models. Anaerobe 24：102-106, 2013

12）Zocco MA, dal Verme LZ, Cremonini F, et al：Efficacy of Lactobacillus GG in maintaining remission of ulcerative colitis. Aliment Pharmacol Ther 23：1567-1574, 2006

13）Tursi A, Brandimarte G, Papa A, et al：Treatment of relapsing mild-to-moderate ulcerative colitis with the probiotic VSL#3 as adjunctive to a standard pharmaceutical treatment：a double-blind, randomized, placebo-controlled study. Am J Gastroenterol 105：2218-2227, 2010

14）Arthur JC, Perez-Chanona E, Mühlbauer M, et al：Intestinal inflammation targets cancer-inducing activity of the microbiota. Science 338：120-123, 2012

15）Belcheva A, Irrazabal T, Robertson SJ, et al：Gut microbial metabolism drives transformation of MSH2-deficient colon epithelial cells. Cell 158：288-299, 2014

16）Le Leu RK, Hu Y, Brown IL, et al：Synbiotic intervention of Bifidobacterium lactis and resistant starch protects against colorectal cancer development in rats. Carcinogenesis 31：246-251, 2010

17）Walia S, Kamal R, Kanwar SS, et al：Cyclooxygenase as a target in chemoprevention by probiotics during 1,2-dimethylhydrazine induced colon carcinogenesis in rats. Nutr Cancer 67：603-611, 2015.

18）Ishikawa H, Akedo I, Otani T, et al：Randomized trial of dietary fiber and Lactobacillus casei administration for prevention of colorectal tumors. Int J Cancer 116：762-767, 2005

19）Rafter J, Bennett M, Caderni G, et al：Dietary synbiotics reduce cancer risk factors in polypectomized and colon cancer patients. Am J Clin Nutr 85：488-496, 2007

20）Kanazawa H, Nagino M, Kamiya S, et al：Synbiotics reduce postoperative infectious complications：a randomized controlled trial in biliary cancer patients undergoing hepatectomy. Langenbecks Arch Surg 390：104-113, 2005

21）Tanaka K, Yano M, Motoori M, et al：Impact of perioperative administration of synbiotics in patients with esophageal cancer undergoing esophagectomy：a prospective randomized controlled trial. Surgery 152：832-842, 2012

22）Kotzampassi K, Giamarellos-Bourboulis EJ, Voudouris A, et al：Benefits of a synbiotic formula（Synbiotic 2000Forte）in critically ill trauma patients：early results of a randomized controlled trial. World J Surg 30：1848-1855, 2006

23）Motoori M, Yano M, Miyata H, et al：Randomized study of the effect of synbiotics during neoadjuvant chemotherapy on adverse events in esophageal cancer patients. Clin Nutr, 2015. pii：S0261-5614（15）00328-3. doi：10.1016/j.clnu.2015.11.008.